GlassScriptPhysician profile
Elizabeth R Keyes
NPI 1518157916
$1,394.94
in general payments reported to CMS, 2019-2025
12 companies · $373 in 2025
The $373 reported for 2025 was more than what 89% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $275 · 2023: $441 · 2024: $307 · 2025: $373.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,120.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $400.27 | 2022-2025 | Dyanavel Xr |
| Pfizer INC. | $335.31 | 2023-2025 | |
| Sobi, INC | $130.38 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $107.18 | 2022-2024 | Vaxneuvance, Gardasil 9, Vaxelis |
| Sanofi Pasteur INC. | $106.29 | 2023-2025 | |
| Cranial Technologies, INC | $102.48 | 2022-2024 | Doc Band |
| Alk-Abello, INC | $60.26 | 2023 | Odactra, Ragwitek, Grastek |
| Seqirus USA INC | $52.08 | 2022-2025 | Flucelvax |
| Collegium Pharmaceutical, INC. | $35.00 | 2025 | Jornay Pm |
| Tolmar, INC. | $27.85 | 2024 | |
| Glaxosmithkline, LLC. | $21.58 | 2025 | Bexsero, Penmenvy, Rotarix |
| Avion Pharmaceuticals | $16.26 | 2023 | Methylphenidate Hydrochloride |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Keyes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.